Clinical Trials Browser

Phase 1 × INDUSTRY × rilotumumab × Clear all

NCT01791374 2016-02-29

Phase 1/1b Study of Rilotumumab in Japanese Subjects With Advanced Solid Tumors or Advanced or Metastatic Gastric or GEJ

Phase 1 Completed

Gastrointestinal

Stomach Neoplasms